31P-MRS demonstrates a reduction in high-energy phosphates in the occipital lobe of migraine without aura patients

Cephalalgia

Volumn 31, Issue 12, 2011, Pages 1243-1253

  Reyngoudt, Harmen ^a   Paemeleire, Koen ^a   Descamps, Benedicte ^a   De Deene, Yves ^a,b   Achten, Eric ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

31P MRS; creatine kinase reaction; migraine without aura; mitochondria; phantom replacement technique

Indexed keywords

ADENOSINE TRIPHOSPHATE; CREATINE PHOSPHATE; MAGNESIUM; PHOSPHATE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENERGY METABOLISM; FEMALE; HIGH ENERGY PHOSPHATE; HUMAN; MAGNESIUM BLOOD LEVEL; MALE; MIGRAINE; MITOCHONDRION; OCCIPITAL LOBE; PATHOPHYSIOLOGY; PHANTOM; PHOSPHATE BLOOD LEVEL; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; QUANTITATIVE ANALYSIS; METABOLISM; MIGRAINE WITHOUT AURA; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHYSIOLOGY;

ADENOSINE TRIPHOSPHATE; ADULT; ENERGY METABOLISM; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIGRAINE WITHOUT AURA; OCCIPITAL LOBE; PHOSPHATES; PHOSPHOCREATINE;

EID: 79958088506     PISSN: 03331024     EISSN: 14682982     Source Type: Journal    
DOI: 10.1177/0333102410394675     Document Type: Article

References (69)

1. Stovner LJ, Hagen K, Jensen R, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007 ; 27: 193-210 (Pubitemid 46354128)
2. Classification Committee of the International Headache Society. The international classification of headache disorders. 2nd ed. Cephalalgia 2004; 24(Suppl 1): 9-160.
3. Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol. 1981 ; 9: 344-352 (Pubitemid 11106551)
4. Goadsby PJ, Charbit AR, Andreou AP, Akerman S, Holland PR. Neurobiology of migraine. Neuroscience. 2009 ; 161: 327-341
5. Kelman L. The triggers of precipitants of the acute migraine attack. Cephalalgia. 2007 ; 27: 394-402 (Pubitemid 46632598)
6. Goadsby PJ. Pathophysiology of migraine. Neurol Clin. 2009 ; 27: 335-360
7. Olesen J. The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacol Ther. 2008 ; 120: 157-171
8. Schoenen J. Pathogenesis of migraine: the biobehavioural and hypoxia theories reconciled. Acta Neurol Belg. 1994 ; 94: 79-86
9. Schoenen J. Cortical electrophysiology in migraine and possible pathogenic implications. Clin Neurosci. 1998 ; 5: 10-17 (Pubitemid 28106787)
10. Russell MB, Olesen J. The genetics of migraine without aura and migraine with aura. Cephalalgia. 1993 ; 13: 245-248 (Pubitemid 23233130)
11. Russell MB, Iselius L, Olesen J. Inheritance of migraine investigated by complex segregation analysis. Hum Genet. 1995 ; 96: 726-730
12. De Vries B, Frants RR, Ferrari MD, Van Den Maagdenberg AM. Molecular genetics of migraine. Hum Genet. 2009 ; 126: 115-132
13. Antilla V, Stefansson H, Kallela M, et al. (International Headache Genetics Consortium). Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat Genet. 2010 ; 42 (10). 869-873
14. Di Lorenzo C, Pierelli F, Coppola G, et al. Mitochondrial DNA haplogroups influence the therapeutic response to riboflavin in migraineurs. Neurology. 2009 ; 72: 1588-1594
15. Majamaa K, Finnila S, Turkka J, Hassinen IE. Mitochondrial DNA haplogroup U as a risk factor for occipital stroke in migraine. Lancet. 1998 ; 352: 455-456 (Pubitemid 28362800)
16. Wang Q, Ito M, Adams K, et al. Mitochondrial DNA control region sequence variation in migraine headache and cyclic vomiting syndrome. Am J Med Genet A. 2004 ; 131: 50-58 (Pubitemid 39434794)
17. Barrett CF, Van Den Maagdenberg AM, Frants RR, Ferrari MD. Familial hemiplegic migraine. Adv Genet. 2008 ; 63: 57-83
18. Kemp GJ. Non-invasive methods for studying brain energy metabolism: what they show and what it means. Dev Neurosci. 2000 ; 22: 418-428
19. Welch KM, Levine SR, D'Andrea G, Helpern JA. Brain pH in migraine: An in vivo phosphorus-31 magnetic resonance spectroscopy study. Cephalalgia. 1988 ; 8: 273-277
20. Welch KM, Levine SR, D'Andrea G, Schultz LR, Helpern JA. Preliminary observations on brain energy metabolism in migraine studied by in vivo phosphorus 31 NMR spectroscopy. Neurology. 1989 ; 39: 538-541 (Pubitemid 19105770)
21. Barbiroli B, Montagna P, Cortelli P, et al. Complicated migraine studied by phosphorus magnetic resonance spectroscopy. Cephalalgia. 1990 ; 10: 263-272
22. Sacquegna T, Lodi R, De Carolis P, et al. Brain energy metabolism studied by 31P-MR spectroscopy in a case of migraine with prolonged aura. Acta Neurol Scand. 1992 ; 86: 376-380
23. Barbiroli B, Montagna P, Cortelli P, et al. Abnormal brain and energy metabolism shown by 31P magnetic resonance spectroscopy in patients affected by migraine with aura. Neurology. 1992 ; 42: 1209-1214
24. Montagna P, Cortelli P, Monari L, et al. 31P-Magnetic resonance spectroscopy in migraine without aura. Neurology. 1994 ; 44: 666-669
25. Montagna P. Magnetic resonance spectroscopy in migraine. Cephalalgia. 1995 ; 15: 323-327
26. Uncini A, Lodi R, Di Muzio A, et al. Abnormal brain and muscle energy metabolism shown by 31P-MRS in familial hemiplegic migraine. J Neurol Sci. 1995 ; 129: 214-222
27. Lodi R, Montagna P, Soriani S, et al. Deficit of brain and skeletal muscle bioenergetics and low brain magnesium in juvenile migraine: an in vivo 31P magnetic resonance spectroscopy interictal study. Pediatr Res. 1997 ; 42: 866-871
28. Boska MD, Welch KM, Barker PB, Nelson JA, Schultz L. Contrasts in cortical magnesium, phospholipid and energy metabolism between migraine syndromes. Neurology. 2002 ; 58: 1227-1233 (Pubitemid 34411867)
29. Schulz UG, Blamire AM, Corkill RG, Davies P, Styles P, Rothwell PM. Association between cortical metabolite levels and clinical manifestations of migrainous aura: an MR-spectroscopy study. Brain. 2007 ; 130: 3102-3110 (Pubitemid 350209062)
30. Montagna P, Sacquegna T, Martinelli P, et al. Mitochondrial abnormalities in migraine. Preliminary findings. Headache. 1988 ; 28: 477-480
31. Lodi R, Iotti S, Cortelli P, et al. Deficient energy metabolism is associated with low free magnesium in the brains of patients with migraine and cluster headache. Brain Res Bull. 2001 ; 54: 437-441 (Pubitemid 32288727)
32. Bottomley PA, Hardy CJ. Rapid, reliable in vivo assay of human phosphate metabolites by nuclear magnetic resonance. Clin Chem. 1989 ; 35: 392-395 (Pubitemid 19086686)
33. Griffey RH, Brown MS, Bankhurst AD, Sibbitt RR, Sibbit WL. Depletion of high-energy phosphates in the central nervous system of patients with systemic lupus erythematosus, as determined by phosphorus-31 nuclear magnetic resonance spectroscopy. Arthritis Rheum. 1990 ; 33: 827-833 (Pubitemid 20205762)
34. Sappey-Marinier D, Vighetto A, Peyron R, Broussolle E, Bonmartin A. Phosphorus and proton magnetic resonance spectroscopy in episodic ataxia type 2. Ann Neurol. 1999 ; 46: 256-259 (Pubitemid 29382884)
35. Stamelou M, Pilatus U, Reuss A, et al. In vivo evidence for cerebral depletion in high-energy phosphates in progressive supranuclear palsy. J Cereb Blood Flow Metab. 2009 ; 29: 861-870
36. Hattingen E, Magerkurth J, Pilatus U, et al. Phosphorus and proton magnetic resonance spectroscopy demonstrates mitochondrial dysfunction in early and advanced Parkinson's disease. Brain. 2009 ; 132: 3285-3297
37. Pietz J, Rupp A, Ebinger F, et al. Cerebral energy metabolism in phenylketonuria: findings by quantitative in vivo 31P-MR spectroscopy. Pediatr Res. 2003 ; 53: 654-662 (Pubitemid 36406737)
38. Petroff OA, Prichard JW, Behar KL, Alger JR, Den Hollander JA, Shulman RG. Cerebral intracellular pH by 31P nuclear magnetic resonance spectroscopy. Neurology. 1985 ; 35: 781-788 (Pubitemid 15025280)
39. Iotti S, Frassineti C, Alderighi L, Sabatini A, Vacca A, Barbiroli B. In vivo assessment of free magnesium concentration in human brain by 31P-MRS. A new calibration curve based on a mathematical algorithm. NMR Biomed. 1996 ; 9: 24-32 (Pubitemid 26310156)
40. Kemp GJ, Roussel M, Bendahan B, Le Fur Y, Cozzone PJ. Interrelations of ATP synthesis and proton handling in ischaemic exercise studied by 31P magnetic resonance spectroscopy. J Physiol. 2001 ; 535: 901-928 (Pubitemid 32894498)
41. Reyngoudt H, De Deene Y, Descamps B, Paemeleire K, Achten E. 1H-MRS of brain metabolites in migraine without aura: absolute quantification using the phantom replacement technique. Magn Reson Mater Phy. 2010 ; 23: 227-241
42. Ishii K, Sasaki M, Kitagaki H, Sakamato S, Yamaji S, Maeda K. Regional difference in cerebral blood flow and oxidative metabolism in human cortex. J Nucl Med. 1996 ; 37: 1086-1088 (Pubitemid 26329510)
43. Reivich M, Kuhl D, Wolf A, et al. The [18]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res. 1979 ; 44: 127-137 (Pubitemid 9089586)
44. Loessner A, Alavi A, Lewandrowski KU, Mozley D, Souder E, Gur RE. Regional cerebral function determined by FDG-PET in healthy volunteers: normal pattern and changes with age. J Nucl Med. 1995 ; 36: 1141-1149
45. Ramadan NM, Halvorson H, Vande-Linde A, Levine SR, Helpern JA, Welch KM. Low brain magnesium in migraine. Headache. 1989 ; 29: 590-593 (Pubitemid 20318945)
46. Wiesinger H, Hamprecht B, Dringen R. Metabolic pathways for glucose in astrocytes. Glia. 1997 ; 21: 22-34 (Pubitemid 27389637)
47. Sibson NR, Dhankhar A, Mason GF, Rothman DL, Behar KL, Shulman RG. Stoichiometric coupling of brain glucose metabolism and glutamatergic neuronal activity. Proc Natl Acad Sci USA. 1998 ; 95: 316-321 (Pubitemid 28103951)
48. Siesjo BK In: Brain energy metabolism. New York: John Wiley & Sons ; 1978: 101-130.
49. Benarroch EE. Glycogen metabolism: metabolic coupling between astrocytes and neurons. Neurology. 2010 ; 74: 919-923
50. Prichard J, Rothman D, Novotny E, et al. Lactate rise detected by 1H NMR in human visual cortex during physiologic stimulation. Proc Natl Acad Sci USA. 1991 ; 88: 5829-5831 (Pubitemid 21914839)
51. Kim J, Kim S, Suh SI, Koh SB, Park KW, Oh K. Interictal metabolic changes in episodic migraine: a voxel-based FDG-PET study. Cephalalgia. 2009 ; 30: 53-61
52. Lodi R, Kemp GJ, Montagna P, et al. Quantitative analysis of skeletal muscle bioenergetics and proton efflux in migraine and cluster headache. J Neurol Sci. 1997 ; 146: 73-80 (Pubitemid 27116056)
53. Sangiorgi S, Mochi M, Riva R, et al. Abnormal platelet mitochondrial function in patients affected by migraine with and without aura. Cephalalgia. 1994 ; 14: 21-23 (Pubitemid 24109965)
54. Okada H, Araga S, Takeshima T, Nakashima K. Plasma lactic acid and pyruvic acid levels in migraine and tension-type headache. Headache. 1997 ; 38: 39-42
55. Eleff SM, Barker PB, Blackband SJ, et al. Phosphorous magnetic resonance spectroscopy of patients with mitochondrial cytopathies demonstrates decreased levels of brain phosphocreatine. Ann Neurol. 1990 ; 27: 626-630 (Pubitemid 20177410)
56. Di Mauro S, Moraes CT. Mitochondrial encephalomyopathies. Arch Neurol. 1993 ; 50: 1197-1208 (Pubitemid 23327777)
57. Kato T, Murashita J, Shioiri T, Terada M, Inubushi T, Kato N. Photic stimulation-induced alteration of brain energy metabolism measured by 31P-MR spectroscopy in patients with MELAS. J Neurol Sci. 1998 ; 155: 182-185 (Pubitemid 28139018)
58. Möller HE, Kurlemann G, Pützler M, Wiedermann D, Hilbich T, Fiedler B. Magnetic resonance spectroscopy in patients with MELAS. J Neurol Sci. 2005 ; 229/230: 131-139 (Pubitemid 40341576)
59. Bresolin N, Martinelli P, Barbiroli B, et al. Muscle mitochondrial DNA deletion and 31P-NMR spectroscopy alterations in a migraine patient. J Neurol Sci. 1991 ; 104: 182-189
60. Klopstock T, May A, Seibel P, Papagiannuli E, Diener HC, Reichmann H. Mitochondrial DNA in migraine with aura. Neurology. 1996 ; 46: 1735-1738 (Pubitemid 26185803)
61. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology. 1998 ; 50: 466-470
62. Sandor PS, Di Clemente L, Coppola G, et al. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized trial. Neurology. 2005 ; 64: 713-715 (Pubitemid 40261904)
63. Schoonman GG, Sandor PS, Agosti RM, et al. Normobaric hypoxia and nitroglycerin as trigger factors for migraine. Cephalalgia. 2006 ; 26: 816-819 (Pubitemid 43882990)
64. Irwin RW, Yao J, Hamilton RT, Cadenas E, Brinton RD, Nilsen J. Progesterone and estrogen regulate oxidative metabolism in brain mitochondria. Endrocrinology. 2008 ; 149: 3167-3175 (Pubitemid 351724522)
65. Sone T, Miyazaki Y, Ogawa K, Satake T. Effects of excessive noradrenaline on cardiac mitochondrial calcium transport and oxidative phosphorylation. Jpn Circ J. 1984 ; 48: 492-497 (Pubitemid 14056736)
66. Valentino RJ, Curtis AL, Page ME, Pavcovich LA, Florin-Lechner SM. Activation of the locus ceruleus brain noradrenergic system during stress: circuitry, consequences, and regulation. Adv Pharmacol. 1998 ; 42: 781-784
67. Sato H, Fox K, Daw NW. Effect of electrical stimulation of locus coeruleus on the activity of neurons in the cat visual cortex. J Neurophysiol. 1989 ; 62: 946-958 (Pubitemid 19260860)
68. Welch KM. Migraine: a biobehavioural disorder. Arch Neurol. 1987 ; 44: 323-327
69. Mochi M, Sangiorgi S, Cortelli P, Riva R, Crisci M, Monari L. Migraine with aura: a threshold character with mitochondrial enzyme deficiency. Neurology. 1991 ; 41 (Suppl 1). 1-254